EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country survey

Charlotte Verbeke iD, Jolien Broekmans iD, Elise Schoefs, Silène Ten Seldam, Kate Morgan, Katie Joyner, Eilidh Duncan, Ariel Aviv, Varda Shoham, Michel Delforge, Anneleen Vanhellemont, Rosanne Janssens und 2 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0356989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Charlotte Verbeke und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Multiple Myeloma, Patient Participation, Decision Making, Shared. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Myeloma Patients Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Shared decision-making (SDM) can enhance patient involvement in treatment and care decisions. Still, questions remain on how multiple myeloma (MM) patients perceive and evaluate their current and desired roles in these decisions and whether characteristics influence their willingness to be involved. This study aimed to identify I) the current knowledge of the concept SDM among MM patients and healthcare professionals (HCPs) involved in MM care, II) how MM patients are and want to be involved in decisions, and III) differences in the willingness to be involved in view of participants’ characteristics (e.g., age, gender, health literacy).

Methods

An online survey for MM patients and HCPs involved in MM care was launched in October and December 2023, respectively. The data was statistically analyzed.

Results

558 patients and 89 HCPs completed the survey. Most patients lived in the Netherlands (28.7%), Israel (23.5%) and Belgium (15.8%), and most HCPs lived in France (39.3%) and Israel (24.7%). 56.6% of the patients and 28.1% of the HCPs had not previously heard of SDM. Almost all patients (96.1%) indicated wanting to be involved in treatment decisions. 3.9% of patients indicated not wanting to be involved, because they did not know whether they would have enough knowledge to decide or because they were used to the HCP deciding. All HCPs believed that MM patients should be involved if they want to. Patients had higher involvement scores at recent consultations and desired to be more involved in initial decisions following diagnosis. The survey revealed no significant differences in participants’ involvement and their characteristics.

Conclusion

MM patients want to be involved in decisions and HCPs are willing to involve MM patients. However, challenges remain concerning the practical implementation of involvement and SDM. This highlights the importance of understanding SDM and patient involvement and assessing the individual needs and preferences of MM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPatient ParticipationDecision Making, SharedHumansFemaleMaleMiddle AgedAgedSurveys and QuestionnairesAdultAged, 80 and overHealth PersonnelDecision Making

Autor:innen und Institutionen

  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Myeloma Patients Europe, Brussels, Belgium.
  • Department of Hematology, Ha'Emek medical center, Afula, Israel.
  • AMEN association, Kiron, Israel.
  • Department of Hematology, University Hospital Leuven, Leuven, Belgium.
  • Department of Public Health and Primary Care, Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium.

ORCID-Profile: Charlotte Verbeke, Jolien Broekmans

Förderung

  • Myeloma Patients Europe

Zitieren

APA

Verbeke, C., Broekmans, J., Schoefs, E., Ten Seldam, S., Morgan, K., Joyner, K., Duncan, E., Aviv, A., Shoham, V., Delforge, M., Vanhellemont, A., Janssens, R., Bohyn, A., & Huys, I. (2026). Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country survey. PLOS One. https://doi.org/10.1371/journal.pone.0356989

Vancouver

Verbeke C, Broekmans J, Schoefs E, Ten Seldam S, Morgan K, Joyner K, et al. Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country survey. PLOS One. 2026. doi:10.1371/journal.pone.0356989

BibTeX
@article{Verbeke2026,
  author = {Verbeke, Charlotte and Broekmans, Jolien and Schoefs, Elise and Ten Seldam, Silène and Morgan, Kate and Joyner, Katie and Duncan, Eilidh and Aviv, Ariel and Shoham, Varda and Delforge, Michel and Vanhellemont, Anneleen and Janssens, Rosanne and Bohyn, Alexandre and Huys, Isabelle},
  title = {Enhancing patient involvement through shared decision-making: Are we there yet in multiple myeloma? Findings from a cross-country survey},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0356989}
}
Kostenlos starten →